Jenny Wei, PhD
Dr. Wei's area of research expertise is in geriatric pharmacoepidemiology, with specific focus areas on drug safety, drug effectiveness, and quality of medication prescribing in older adults, especially those with pain, neurodegenerative diseases (e.g., Alzheimer’s disease and related dementia [ADRD]), and nursing home stays. In addition to her research expertise, she will make important contributions to the teaching mission; including graduate student teaching and mentoring, as well as the service mission of the College.
- PhD, University of Maryland School of Pharmacy, Pharmaceutical Health Services Research
- MSc, National Taiwan University, Health Policy and Management
- 2020 - The American Society of Clinical Pharmacology and Therapeutics (ASCPT)’s William B Abrams Award in Geriatric Clinical Pharmacology
- 2018 - Excellent Awards for Assistant Professors, University of Florida
- 2017-2019 - Junior Scholar Award, NIA Claude D. Pepper Older Americans Independence Center grant at University of Florida
- 2011 - Best Research Award, Treatment for Homeless Program Technical Assistance Workshop, Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (DHHS)
- 2008-2012 - Rho Chi Honor Society Membership
Wei YJ, Chen C, Schmidt S, Lewis OL, Winterstein AG. Trajectories of Prescription Opioid Dose and Risk of Opioid-Related Adverse Events Among Older Adults—A Nested Case-Control Study. PLOS Medicine. 2022 Mar; 19(3): e1003947. doi: 10.1371/journal.pmed.1003947.
Chen C, Winterstein AG, Lo-Ciganic WH, Tighe PJ, Wei YJ. Perioperative Use of Gabapentinoids and Risk for Postoperative Long-Term Opioid Use in Older Adults Undergoing Total Knee or Hip Arthroplasty. J Arthroplasty. 2022 May 13;S0883-5403(22)00569-1. doi: 10.1016/j.arth.2022.05.018.
Chen C, Winterstein AG, Lo-Ciganic WH, Tighe PJ, Wei YJ. Concurrent use of prescription opioids and gabapentinoids and risk for fall-related injury among older Medicare beneficiaries with chronic non-cancer pain. PLOS Medicine. 2022 March;19(3):e1003921. doi: 10.1371/journal.pmed.1003921.
Albogami Y, Wei YJ, Winterstein AG. Generalizability and Accuracy of IBM MarketScan Health Risk Assessment Instrument Data for Augmentation of Commercial Claims Data. Pharmacoepidemiol Drug Saf, 2022 Jan;31(1):100-104. doi: 10.1002/pds.5371.
Wei YJ, Chen C, Winterstein AG. Discontinuation of Long-term Opioid Therapy in Patients With versus Without Alzheimer Disease and Related Dementia. American Journal of Preventive Medicine. 2022 Feb;62(2):270-274. doi: 10.1016/j.amepre.2021.07.020.
Chen C, Winterstein AG, Lo-Ciganic WH, Tighe PJ, Wei YJ. Concurrent Use of Prescription Opioids and Gabapentinoids in Older Medicare Beneficiaries with Chronic Noncancer Pain, 2011-2018. American Journal of Preventive Medicine, 2021 Nov 18; S0749-3797(21)00510-9. doi: 10.1016/j.amepre.2021.08.024.
Wei YJ, Chen C, Schmidt S, Fillingim RB, Reid MC, DeKosky S, Solberg L, Pahor M, Winterstein AG. Uncontrolled Pain and Risk for Depression and Behavioral Symptoms in Patients with Dementia. Journal of the American Medical Directors Association. 2021. June 2; S1525-8610(21)00474-6.
Wei YJ, Schmidt S, Chen C, Fillingim RB, Reid MC, DeKosky S, Solberg L, Pahor M, Brumback B, Winterstein AG. Quality of Opioid Prescribing in Older Adults With or Without Alzheimer Disease and Related Dementia. Alzheimer’s Research & Therapy. 2021. 12;13(1):78.
Li Y, Delcher C, Reisfield GM, Wei YJ, Brown JD, and Winterstein AG. Utilization patterns of skeletal muscle relaxants among commercially insured adults in the United States from 2006 to 2018. Pain Medicine. 2021 March. doi: 10.1093/pm/pnab088.
Albogami Y, Cusi K, Daniels MJ, Wei YJ, Winterstein AG. Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352. Diabetes Care. 2021 Aug;44(8):e167
Albogami Y, Cusi K, Daniels MJ, Wei YJ, Winterstein AG. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients Q:1 With Type 2 Diabetes. Diabetes Care. 2021 Apr 19;dc201794. doi: 10.2337/dc20-1794.
Zhu Y, Hampp C, Wang X, Albogami Y, Wei YJ, Brumback BA, Roussos-Ross D, Winterstein AG. Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy. Pharmacoepidemiol Drug Saf. 2020 Sep 9.
Wei YJ, Solberg L, Chen C, Fillingim R, Pahor M, DeKosky S, Winterstein AG. Agreement of Minimum Data Set 3.0 Depression and Behavioral Symptoms with Clinical Diagnosis in a Nursing Home. Aging and Mental Health. 2020 May 25;1-6. doi: 10.1080/13607863.2020.1758921.
Li Y, Delcher C, Wei YJ, Reisfield GM, Brown J, Patrick T, Winterstein AG. Risk of opioid overdose associated with concomitant use of opioids and skeletal muscle relaxants: a population-based cohort study. Clinical Pharmacology & Therapeutics. 2020 Feb 5. doi: 10.1002/cpt.1807.
Muñoz MA, Dal Pan GJ, Wei YJ, Delcher C, Xiao, H, Kortepeter CM, Winterstein AG. Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility. Drug Saf. Jan 2020. https://doi.org/10.1007/s40264-019-00897-0.
Wei YJ, Chen C, Fillingim R, Schmidt SO, Winterstein AG. Trends in Prescription Opioid Use and Dose Trajectories Before Opioid Use Disorder or Overdose in US Adults from 2006-2016: a Cross-Sectional Study. PLOS Medicine. Nov 2019;16(11):e1002941.
Wei YJ, Chen C, Sarayani A(g), and Winterstein AG. Performance of Centers for Medicare and Medicaid Services' Opioid Overutilization Criteria for Classifying Beneficiaries with Opioid Use Disorder or Overdose. JAMA. Feb 2019; 321(6):609-611.
Wei YJ, Chen C, Schmidt SO, Lo-Ciganic WH, Winterstein AG. Trends in Prior Receipt of Prescription Opioid or Adjuvant Analgesics Among Patients with Incident Opioid Use Disorder or Opioid-Related Overdose From 2006 to 2016. Drug and Alcohol Dependence. Nov 2019 ;204:107600.
Wei YJ, Solberg L, Chen C, Fillingim R, Pahor M, DeKosky S, Winterstein A. Pain Assessments in MDS 3.0—Agreement with Vital Sign Pain Records of Nursing Home Residents. Journal of the American Geriatrics Society. Nov 2019. doi: 10.1111/jgs.16122. [Epub ahead of print].
Chen C, Winterstein AG, Fillingim B, Wei YJ. Body weight, Frailty, and Chronic pain among US Older Adults: a Cross-sectional Study. BMC Geriatrics. 2019; May 24;19(1):143.
Alrwisan A, Antonelli PJ, Brumback BA, Wei YJ, Winterstein AG. Concomitant Use of Quinolones and Stimulants and the Risk of Adverse Cardiovascular Symptoms: A Retrospective Cohort Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. Dec 2019, 39 (12): 1167-1178.
Munoz M, Delcher C, Dal pan GJ, Korteperter CM, Wu E, Wei YJ, Xiao H, Winterstein AG. Impact of a New Consumer Form on Adverse Event Reporting to the United States Food and Drug Administration. Pharmacotherapy. Nov 2019. doi: 10.1002/phar.2325. [Epub ahead of print].
Li Y, Delcher C, Brown J, Wei YJ, Reisfield GM, Winterstein AG. Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: an interrupted time series analysis. Drug and Alcohol Dependence. Sep 2019; 202:172-177.
Chen C, Hartzema AG, Xiao H, Wei YJ, Chaudhry N, Ewelukwa O, Glover SC, Zimmermann EM. Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy. Inflammatory Bowel Disease. Jul 2019; 25(8):1417-1427.
Wei YJ, Zhu Y, Liu W, Bussing R, and Winterstein AG. Prevalence of and Factors Associated With Long-term Concomitant Use of Stimulants and Opioids Among Adults with Attention- Deficit/Hyperactivity Disorder. JAMA Network Open. 2018; 1(4):e181152.
Alrwisan A, Antonelli PJ, Brumback BA, Wei YJ, Winterstein AG. Azithromycin and Sensorineural Hearing Loss in Adults: A Retrospective Cohort Study. Otology and Neurotology. 2018; 39(8):957-963.
Hincapie-Castillo JM, Wei YJ, Winterstein AG. Clinical utility and perils of prescription drug monitoring program-based alert systems. Pain. 2018; 159(4):804-805.
Wei YJ, Simoni-Wastila L, Albrecht JS, Huang TY, Moyo P, Khokhar B, Harris I, Langenberg P, Netzer G, Lehmann SW. The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study. International Journal of Geriatric Psychiatry. 2018; 33(2):e212-e220.
Wei YJ, Liu X, Rao N, McPherson M, Jones MB, Bussing R, and Winterstein AG. Physical health outcomes in preschoolers with prior authorization for antipsychotics. The Journal of Child and Adolescent Psychopharmacology. 2017; 27(9):833-839.
Albrecht JS, Khokhar B, Huang TY, Wei YJ, Harris I, Patience M, Hur P, Netzer G, Lehmann SW, Langenberg P, Simoni-Wastila L. Adherence and Healthcare Utilization among Older Adults with COPD and Depression. Respiratory Medicine. 2017; 129:53-58.
Wei YJ, Simoni-Wastila L, Lucas JA, and Brandt N. Fall and fracture risk in nursing home residents with moderate-to-severe behavioral symptoms of Alzheimer’s disease and related dementias initiating antidepressants or antipsychotics. The Journal of Gerontology: Series A: Medical Sciences. 2017; 72(5):695-702.
Wei YJ, Simoni-Wastila L, Zuckerman IH, Brandt N, Lucas JA. Algorithm for Identifying Nursing Home Days Using Medicare Claims and Minimum Data Set Assessment Data. Medical care. 2016; 54(11):e73-e77.
Albrecht JS, Park Y, Hur P, Huang TY, Harris I, Netzer G, Lehmann SW, Langenberg P, Khokhar B, Wei YJ, and Simoni-Wastila L. Adherence to Maintenance Medications among Older Adults with Chronic Obstructive Pulmonary Disease: The Role of Depression. Annals of the American Thoracic Society. 2016 13(9):1497-504.
Simoni-Wastila L, Wei YJ*(co-first & corresponding author), Lucas JA, Brandt N, Moyo P, Huang TY, Franey C, Zuckerman IH. Mortality Risk of Antipsychotic Dose and Duration in Nursing Home Residents with Chronic or Acute Indications. Journal of the American Geriatrics Society. 2016; 64(5):973-80.
Huang TY, Wei YJ, Moyo P, Zuckerman IH, Lucas JA, Simoni-Wastila L. Treated behavioral symptoms and mortality among Medicare nursing home residents with Alzheimer’s disease and related dementias. Journal of the American Geriatrics Society. 2015; 63(9): 1757-65.
Wei YJ, Simoni-Wastila L. Response to Lapane and colleagues. Journal of the American Geriatrics Society. 2015; 63(4):834.
Wei YJ, Palumbo FB, Simoni-Wastila L, Shulman L, Stuart B, Beardsley R, Brown C. Relationships between antiparkinson drug nonadherence, modifications, and healthcare utilization and expenditures. Parkinsonism and Related Disorders. 2015; 21(1):36-41.
Wei YJ, Simoni-Wastila L, Zuckerman IH, Huang TY, Brandt N, Moyo P, Lucas JA. Quality of psychopharmacological medication prescribing and mortality in Medicare beneficiaries in nursing homes. Journal of the American Geriatrics Society. 2014; 62(8):1490-504.
Simoni-Wastila L, Wei YJ (corresponding author), Luong M, Franey C, Huang TY, Rattinger G, Zuckerman IH, Brandt N, Lucas JA. Quality of psychopharmacological medication use in nursing home residents. Research in Social and Administrative Pharmacy. 2014; 10(3):494-507.
Wei YJ, Palumbo FB, Simoni-Wastila L, Shulman L, Stuart B, Beardsley R, Brown C. Antiparkinson drug adherence and its association with healthcare utilization and economic outcomes in a Medicare Part D population. Value in Health. 2014; 17(2):196-204.
Qian J, Simoni-Wastila L, Rattinger B, Zuckerman I, Lehmann S, Wei YJ, Stuart B. Association between depression and maintenance medication adherence among Medicare beneficiaries with COPD. International Journal of Geriatric Psychiatry. 2014;29(1):49-5.
Wei YJ, Palumbo FB, Simoni-Wastila L, Shulman L, Stuart B, Beardsley R, Brown C. Antiparkinson drug use and adherence in Medicare Part D beneficiaries with Parkinson’s disease: patterns and associated factors. Clinical Therapeutics. 2013; 35 (10):1513–1525.e1.
Simoni-Wastila L, Wei YJ (corresponding author), Qian J, Zuckerman IH, Stuart B, Shaffer T, Dalal A, Bryant-Comstock L. 2012. Association of COPD maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. American Journal of Geriatric Pharmacotherapy. 2012;10(3):201-1.
Simoni-Wastila L, Qian J, Wei YJ, Zuckerman IH, Stuart B, Shaffer T, Dalal A, Bryant-Comstock L. Should Medicare rely on high drug spending as a criterion for medication therapy management programs? Journal of Pharmaceutical Health Services Research. 2012; 3 (4): 213-219
Wei YJ, Stuart B, Zuckerman IH. Use of antiparkinson medications among the elderly Medicare beneficiaries with Parkinson’s disease. American Journal of Geriatric Pharmacotherapy. 2010; 8(4):384-94.
Cheng SH, Wei YJ, Chang HJ. Quality competition among hospitals: The effects of perceived quality and perceived expensiveness. American Journal of Medical Quality. 2006; 21(1):68-75.
Wei YJ, Chung KP, Cheng SH. The evolution of healthcare quality assessment: From accreditation to report card system. Taiwan Journal of Public Health. 2005; 24(4): 275-283